Discovering the interactome, functions, and clinical relevance of enhancer RNAs in kidney renal clear cell carcinoma

Enhancer RNA (eRNA) has emerged as a key player in cancer biology, influencing various aspects of tumor development and progression. In this study, we investigated the role of eRNAs in kidney renal clear cell carcinoma (KIRC), the most common subtype of renal cell carcinoma. Leveraging high-throughp...

Full description

Saved in:
Bibliographic Details
Published in:BMC medical genomics 2025-01, Vol.18 (1), p.3-14, Article 3
Main Authors: Sun, Zhaohui, Du, Haojie, Zheng, Xudong, Zhang, Hepeng, Hu, Huajie
Format: Article
Language:English
Subjects:
Binding sites
Bioinformatics
Biomarkers
Carcinoma, Renal cell
Care and treatment
Cell cycle
Development and progression
E-P loops
ENSR00000305834
eRNA
Genes
Genetic aspects
Genomes
Glioma
Health aspects
Hypoxia
Immune response
Kidney cancer
KIRC
Liver cancer
Medical research
Next-generation sequencing
Peptides
Prediction models
Proteins
Regression analysis
Renal cell carcinoma
RNA
SLC15A2
Therapeutic targets
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c479t-5a9cae9e6891b507f3dee83b11f853f9a680a4581cd5caa7ff29339a5de228843
container_end_page 14
container_issue 1
container_start_page 3
container_title BMC medical genomics
container_volume 18
creator Sun, Zhaohui
Du, Haojie
Zheng, Xudong
Zhang, Hepeng
Hu, Huajie
description Enhancer RNA (eRNA) has emerged as a key player in cancer biology, influencing various aspects of tumor development and progression. In this study, we investigated the role of eRNAs in kidney renal clear cell carcinoma (KIRC), the most common subtype of renal cell carcinoma. Leveraging high-throughput sequencing data and bioinformatics analysis, we identified differentially expressed eRNAs in KIRC and constructed eRNA-centric regulatory networks. Our findings revealed that up-regulated eRNAs in KIRC potentially regulate immune response and hypoxia pathways, while down-regulated eRNAs may impact ion transport, cell cycle, and metabolism. Furthermore, we developed a diagnostic prediction model based on eRNA expression profiles, demonstrating its effectiveness in KIRC diagnosis. Finally, we elucidated the regulatory mechanism of an eRNA (ENSR00000305834) on the expression of SLC15A2, a potential prognostic biomarker in KIRC, through bioinformatics analysis and in vitro validation experiments. In summary, Our study highlights the clinical significance of eRNAs in KIRC and underscores their potential as therapeutic targets.
doi_str_mv 10.1186/s12920-024-02081-5
format article
fullrecord <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_f1321efc3ae44ea680b81f276212e892</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A822279270</galeid><doaj_id>oai_doaj_org_article_f1321efc3ae44ea680b81f276212e892</doaj_id><sourcerecordid>A822279270</sourcerecordid><originalsourceid>FETCH-LOGICAL-c479t-5a9cae9e6891b507f3dee83b11f853f9a680a4581cd5caa7ff29339a5de228843</originalsourceid><addsrcrecordid>eNptkt1u1DAQRiMEoqXwAlygSNyA1JTYjmP7Cq3K30oVSAWurVlnvOuS2MVOVvTtcXZL6SIUWRk5Z46dT1MUz0l9Rohs3yRCFa2rmjZ51ZJU_EFxTATnlRSqeXivPiqepHRV123NFXlcHDEleEOkOC7Gdy6ZsMXo_LocN1g6P2IEM4YBT0s7eTO64NNpCb4rTe-8M9CXEXvcgjdYBlui38xlLC8_L1LuL3-4zuNNhnxGTY8QS4N9LiEa58MAT4tHFvqEz27fJ8X3D--_nX-qLr58XJ4vLirTCDVWHJQBVNhKRVa8FpZ1iJKtCLGSM6uglTU0XBLTcQMgrKWKMQW8Q0qlbNhJsdx7uwBX-jq6AeKNDuD0biPEtYY4unxFbQmjBK1hgE2Ds3kliaWipYSiVDS73u5d19NqwM6gHyP0B9LDL95t9DpsNSGtyhqeDa9uDTH8nDCNesjZ52DAY5iSZoSThjMp5sNe_oNehSnmOHcUzULWtn-pNeQ_cN6GfLCZpXohKaVCUVFn6uw_VH46HJwJHq3L-wcNrw8aMjPir3ENU0p6-fXykKV71sSQUkR7Fwip9Tykej-kOg-p3g2pnoN4cT_Ku5Y_U8l-A_B44Lk</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3152697366</pqid></control><display><type>article</type><title>Discovering the interactome, functions, and clinical relevance of enhancer RNAs in kidney renal clear cell carcinoma</title><source>Publicly Available Content (ProQuest)</source><source>PubMed Central</source><creator>Sun, Zhaohui ; Du, Haojie ; Zheng, Xudong ; Zhang, Hepeng ; Hu, Huajie</creator><creatorcontrib>Sun, Zhaohui ; Du, Haojie ; Zheng, Xudong ; Zhang, Hepeng ; Hu, Huajie</creatorcontrib><description>Enhancer RNA (eRNA) has emerged as a key player in cancer biology, influencing various aspects of tumor development and progression. In this study, we investigated the role of eRNAs in kidney renal clear cell carcinoma (KIRC), the most common subtype of renal cell carcinoma. Leveraging high-throughput sequencing data and bioinformatics analysis, we identified differentially expressed eRNAs in KIRC and constructed eRNA-centric regulatory networks. Our findings revealed that up-regulated eRNAs in KIRC potentially regulate immune response and hypoxia pathways, while down-regulated eRNAs may impact ion transport, cell cycle, and metabolism. Furthermore, we developed a diagnostic prediction model based on eRNA expression profiles, demonstrating its effectiveness in KIRC diagnosis. Finally, we elucidated the regulatory mechanism of an eRNA (ENSR00000305834) on the expression of SLC15A2, a potential prognostic biomarker in KIRC, through bioinformatics analysis and in vitro validation experiments. In summary, Our study highlights the clinical significance of eRNAs in KIRC and underscores their potential as therapeutic targets.</description><identifier>ISSN: 1755-8794</identifier><identifier>EISSN: 1755-8794</identifier><identifier>DOI: 10.1186/s12920-024-02081-5</identifier><identifier>PMID: 39754187</identifier><language>eng</language><publisher>England: BioMed Central Ltd</publisher><subject>Binding sites ; Bioinformatics ; Biomarkers ; Carcinoma, Renal cell ; Care and treatment ; Cell cycle ; Development and progression ; E-P loops ; ENSR00000305834 ; eRNA ; Genes ; Genetic aspects ; Genomes ; Glioma ; Health aspects ; Hypoxia ; Immune response ; Kidney cancer ; KIRC ; Liver cancer ; Medical research ; Next-generation sequencing ; Peptides ; Prediction models ; Proteins ; Regression analysis ; Renal cell carcinoma ; RNA ; SLC15A2 ; Therapeutic targets</subject><ispartof>BMC medical genomics, 2025-01, Vol.18 (1), p.3-14, Article 3</ispartof><rights>2025. The Author(s).</rights><rights>COPYRIGHT 2025 BioMed Central Ltd.</rights><rights>2025. This work is licensed under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>The Author(s) 2025 2025</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c479t-5a9cae9e6891b507f3dee83b11f853f9a680a4581cd5caa7ff29339a5de228843</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11697625/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/3152697366?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,25731,27901,27902,36989,36990,44566,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39754187$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sun, Zhaohui</creatorcontrib><creatorcontrib>Du, Haojie</creatorcontrib><creatorcontrib>Zheng, Xudong</creatorcontrib><creatorcontrib>Zhang, Hepeng</creatorcontrib><creatorcontrib>Hu, Huajie</creatorcontrib><title>Discovering the interactome, functions, and clinical relevance of enhancer RNAs in kidney renal clear cell carcinoma</title><title>BMC medical genomics</title><addtitle>BMC Med Genomics</addtitle><description>Enhancer RNA (eRNA) has emerged as a key player in cancer biology, influencing various aspects of tumor development and progression. In this study, we investigated the role of eRNAs in kidney renal clear cell carcinoma (KIRC), the most common subtype of renal cell carcinoma. Leveraging high-throughput sequencing data and bioinformatics analysis, we identified differentially expressed eRNAs in KIRC and constructed eRNA-centric regulatory networks. Our findings revealed that up-regulated eRNAs in KIRC potentially regulate immune response and hypoxia pathways, while down-regulated eRNAs may impact ion transport, cell cycle, and metabolism. Furthermore, we developed a diagnostic prediction model based on eRNA expression profiles, demonstrating its effectiveness in KIRC diagnosis. Finally, we elucidated the regulatory mechanism of an eRNA (ENSR00000305834) on the expression of SLC15A2, a potential prognostic biomarker in KIRC, through bioinformatics analysis and in vitro validation experiments. In summary, Our study highlights the clinical significance of eRNAs in KIRC and underscores their potential as therapeutic targets.</description><subject>Binding sites</subject><subject>Bioinformatics</subject><subject>Biomarkers</subject><subject>Carcinoma, Renal cell</subject><subject>Care and treatment</subject><subject>Cell cycle</subject><subject>Development and progression</subject><subject>E-P loops</subject><subject>ENSR00000305834</subject><subject>eRNA</subject><subject>Genes</subject><subject>Genetic aspects</subject><subject>Genomes</subject><subject>Glioma</subject><subject>Health aspects</subject><subject>Hypoxia</subject><subject>Immune response</subject><subject>Kidney cancer</subject><subject>KIRC</subject><subject>Liver cancer</subject><subject>Medical research</subject><subject>Next-generation sequencing</subject><subject>Peptides</subject><subject>Prediction models</subject><subject>Proteins</subject><subject>Regression analysis</subject><subject>Renal cell carcinoma</subject><subject>RNA</subject><subject>SLC15A2</subject><subject>Therapeutic targets</subject><issn>1755-8794</issn><issn>1755-8794</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2025</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNptkt1u1DAQRiMEoqXwAlygSNyA1JTYjmP7Cq3K30oVSAWurVlnvOuS2MVOVvTtcXZL6SIUWRk5Z46dT1MUz0l9Rohs3yRCFa2rmjZ51ZJU_EFxTATnlRSqeXivPiqepHRV123NFXlcHDEleEOkOC7Gdy6ZsMXo_LocN1g6P2IEM4YBT0s7eTO64NNpCb4rTe-8M9CXEXvcgjdYBlui38xlLC8_L1LuL3-4zuNNhnxGTY8QS4N9LiEa58MAT4tHFvqEz27fJ8X3D--_nX-qLr58XJ4vLirTCDVWHJQBVNhKRVa8FpZ1iJKtCLGSM6uglTU0XBLTcQMgrKWKMQW8Q0qlbNhJsdx7uwBX-jq6AeKNDuD0biPEtYY4unxFbQmjBK1hgE2Ds3kliaWipYSiVDS73u5d19NqwM6gHyP0B9LDL95t9DpsNSGtyhqeDa9uDTH8nDCNesjZ52DAY5iSZoSThjMp5sNe_oNehSnmOHcUzULWtn-pNeQ_cN6GfLCZpXohKaVCUVFn6uw_VH46HJwJHq3L-wcNrw8aMjPir3ENU0p6-fXykKV71sSQUkR7Fwip9Tykej-kOg-p3g2pnoN4cT_Ku5Y_U8l-A_B44Lk</recordid><startdate>20250103</startdate><enddate>20250103</enddate><creator>Sun, Zhaohui</creator><creator>Du, Haojie</creator><creator>Zheng, Xudong</creator><creator>Zhang, Hepeng</creator><creator>Hu, Huajie</creator><general>BioMed Central Ltd</general><general>BioMed Central</general><general>BMC</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>ISR</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>P64</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20250103</creationdate><title>Discovering the interactome, functions, and clinical relevance of enhancer RNAs in kidney renal clear cell carcinoma</title><author>Sun, Zhaohui ; Du, Haojie ; Zheng, Xudong ; Zhang, Hepeng ; Hu, Huajie</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c479t-5a9cae9e6891b507f3dee83b11f853f9a680a4581cd5caa7ff29339a5de228843</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2025</creationdate><topic>Binding sites</topic><topic>Bioinformatics</topic><topic>Biomarkers</topic><topic>Carcinoma, Renal cell</topic><topic>Care and treatment</topic><topic>Cell cycle</topic><topic>Development and progression</topic><topic>E-P loops</topic><topic>ENSR00000305834</topic><topic>eRNA</topic><topic>Genes</topic><topic>Genetic aspects</topic><topic>Genomes</topic><topic>Glioma</topic><topic>Health aspects</topic><topic>Hypoxia</topic><topic>Immune response</topic><topic>Kidney cancer</topic><topic>KIRC</topic><topic>Liver cancer</topic><topic>Medical research</topic><topic>Next-generation sequencing</topic><topic>Peptides</topic><topic>Prediction models</topic><topic>Proteins</topic><topic>Regression analysis</topic><topic>Renal cell carcinoma</topic><topic>RNA</topic><topic>SLC15A2</topic><topic>Therapeutic targets</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sun, Zhaohui</creatorcontrib><creatorcontrib>Du, Haojie</creatorcontrib><creatorcontrib>Zheng, Xudong</creatorcontrib><creatorcontrib>Zhang, Hepeng</creatorcontrib><creatorcontrib>Hu, Huajie</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale In Context: Science</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Biological Sciences</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Publicly Available Content (ProQuest)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>BMC medical genomics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sun, Zhaohui</au><au>Du, Haojie</au><au>Zheng, Xudong</au><au>Zhang, Hepeng</au><au>Hu, Huajie</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Discovering the interactome, functions, and clinical relevance of enhancer RNAs in kidney renal clear cell carcinoma</atitle><jtitle>BMC medical genomics</jtitle><addtitle>BMC Med Genomics</addtitle><date>2025-01-03</date><risdate>2025</risdate><volume>18</volume><issue>1</issue><spage>3</spage><epage>14</epage><pages>3-14</pages><artnum>3</artnum><issn>1755-8794</issn><eissn>1755-8794</eissn><abstract>Enhancer RNA (eRNA) has emerged as a key player in cancer biology, influencing various aspects of tumor development and progression. In this study, we investigated the role of eRNAs in kidney renal clear cell carcinoma (KIRC), the most common subtype of renal cell carcinoma. Leveraging high-throughput sequencing data and bioinformatics analysis, we identified differentially expressed eRNAs in KIRC and constructed eRNA-centric regulatory networks. Our findings revealed that up-regulated eRNAs in KIRC potentially regulate immune response and hypoxia pathways, while down-regulated eRNAs may impact ion transport, cell cycle, and metabolism. Furthermore, we developed a diagnostic prediction model based on eRNA expression profiles, demonstrating its effectiveness in KIRC diagnosis. Finally, we elucidated the regulatory mechanism of an eRNA (ENSR00000305834) on the expression of SLC15A2, a potential prognostic biomarker in KIRC, through bioinformatics analysis and in vitro validation experiments. In summary, Our study highlights the clinical significance of eRNAs in KIRC and underscores their potential as therapeutic targets.</abstract><cop>England</cop><pub>BioMed Central Ltd</pub><pmid>39754187</pmid><doi>10.1186/s12920-024-02081-5</doi><tpages>14</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1755-8794
ispartof BMC medical genomics, 2025-01, Vol.18 (1), p.3-14, Article 3
issn 1755-8794
1755-8794
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_f1321efc3ae44ea680b81f276212e892
source Publicly Available Content (ProQuest); PubMed Central
subjects Binding sites
Bioinformatics
Biomarkers
Carcinoma, Renal cell
Care and treatment
Cell cycle
Development and progression
E-P loops
ENSR00000305834
eRNA
Genes
Genetic aspects
Genomes
Glioma
Health aspects
Hypoxia
Immune response
Kidney cancer
KIRC
Liver cancer
Medical research
Next-generation sequencing
Peptides
Prediction models
Proteins
Regression analysis
Renal cell carcinoma
RNA
SLC15A2
Therapeutic targets
title Discovering the interactome, functions, and clinical relevance of enhancer RNAs in kidney renal clear cell carcinoma
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T22%3A50%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Discovering%20the%20interactome,%20functions,%20and%20clinical%20relevance%20of%20enhancer%20RNAs%20in%20kidney%20renal%20clear%20cell%20carcinoma&rft.jtitle=BMC%20medical%20genomics&rft.au=Sun,%20Zhaohui&rft.date=2025-01-03&rft.volume=18&rft.issue=1&rft.spage=3&rft.epage=14&rft.pages=3-14&rft.artnum=3&rft.issn=1755-8794&rft.eissn=1755-8794&rft_id=info:doi/10.1186/s12920-024-02081-5&rft_dat=%3Cgale_doaj_%3EA822279270%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c479t-5a9cae9e6891b507f3dee83b11f853f9a680a4581cd5caa7ff29339a5de228843%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3152697366&rft_id=info:pmid/39754187&rft_galeid=A822279270&rfr_iscdi=true